<SEC-DOCUMENT>0001193125-18-141121.txt : 20180430
<SEC-HEADER>0001193125-18-141121.hdr.sgml : 20180430
<ACCEPTANCE-DATETIME>20180430090555
ACCESSION NUMBER:		0001193125-18-141121
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180424
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180430
DATE AS OF CHANGE:		20180430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKESSON CORP
		CENTRAL INDEX KEY:			0000927653
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				943207296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13252
		FILM NUMBER:		18786939

	BUSINESS ADDRESS:	
		STREET 1:		ONE POST ST
		STREET 2:		MCKESSON PLAZA
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		4159838300

	MAIL ADDRESS:	
		STREET 1:		ONE POST ST
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON HBOC INC
		DATE OF NAME CHANGE:	19990115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON CORP
		DATE OF NAME CHANGE:	19950209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SP VENTURES INC
		DATE OF NAME CHANGE:	19940728
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d542849d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO SECTION 13 OR 15(d) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): April&nbsp;24, 2018 </B></P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>McKesson Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">1-13252</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">94-3207296</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>One&nbsp;Post&nbsp;Street,&nbsp;San&nbsp;Francisco,&nbsp;California</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>94104</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: (415)
<FONT STYLE="white-space:nowrap">983-8300</FONT> </B></P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or former address, if changed since last report.) </B></P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR
<FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR
<FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </TD></TR></TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as
defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934 <FONT STYLE="white-space:nowrap">(&#167;240.12b-2</FONT> of
this chapter). </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;24, 2018, the Board of Directors (the &#147;Board&#148;) of McKesson
Corporation (the &#147;Company&#148;), upon recommendation of the Governance Committee, elected Bradley E. Lerman, as a new director, effective April&nbsp;24, 2018. Mr.&nbsp;Lerman&#146;s term as a director will expire at the Company&#146;s 2018
Annual Meeting of Stockholders unless he is renominated as a director, and elected by stockholders at the annual meeting in accordance with the Company&#146;s majority voting standard. The size of the Board was increased from eight to nine members
in connection with Mr.&nbsp;Lerman&#146;s election. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Lerman, age 61, has been Senior Vice President, General Counsel and Corporate Secretary of
Medtronic plc, a global medical technology, services, and solutions company, since January 2015 and of Medtronic, Inc. since May 2014. Prior to Medtronic, he was Executive Vice President, General Counsel, and Corporate Secretary at Federal National
Mortgage Association (Fannie Mae) from October 2012 to May 2014. From January 2009 to September 2012, Mr.&nbsp;Lerman was Senior Vice President and Chief Litigation Counsel at Pfizer, Inc., a pharmaceutical company. Prior to 2009, he was a partner
at Winston&nbsp;&amp; Strawn LLP and Kirkland&nbsp;&amp; Ellis LLP. Mr.&nbsp;Lerman also previously served as Associate Independent Counsel in the United States Office of Independent Counsel and as Assistant U.S. Attorney in the Northern District of
Illinois for eight years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has not yet assigned Mr.&nbsp;Lerman to any standing committees. The Board has also determined that Mr.&nbsp;Lerman
is independent and meets the applicable director independence requirements of the New York Stock Exchange and the Company&#146;s director independence standards, as adopted by the Board. There was no arrangement or understanding between
Mr.&nbsp;Lerman and any other persons pursuant to which he was selected as a director, and there are no related party transactions between Mr.&nbsp;Lerman and the Company. Effective as of his election, Mr.&nbsp;Lerman will enter into the
Company&#146;s standard form of Indemnification Agreement, which provides for indemnification of the indemnitee to the fullest extent permitted by Delaware law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Lerman will receive compensation for his service on the Board in accordance with the Company&#146;s standard compensatory arrangement for <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors. A description of the Company&#146;s <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation can be found under the caption &#147;Director Compensation&#148; in the
Company&#146;s definitive proxy statement for its 2017 Annual Meeting of Stockholders, which was filed with the Securities and Exchange Commission (the &#147;Commission&#148;) on June&nbsp;16, 2017. Mr.&nbsp;Lerman&#146;s compensation as a <FONT
STYLE="white-space:nowrap">non-employee</FONT> director will be prorated to reflect the remainder of the Company&#146;s annual <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation program. Accordingly, subject to the terms and
conditions of the Company&#146;s 2013 Stock Plan, Mr.&nbsp;Lerman will be granted restricted stock units (&#147;RSUs&#148;) in an amount representing a prorated portion of the annual equity award that was previously granted to <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors. The RSU award was approved by the Board on April&nbsp;25 with an effective date of May&nbsp;30, 2018, or such other date on which the window period opens for trading in the Company&#146;s
securities following the public release of the Company&#146;s earnings for the fourth quarter of fiscal year 2018. The grant date value of the RSUs will be $45,000, and the number of RSUs granted to Mr.&nbsp;Lerman will be determined by dividing
$45,000 by the closing price of the Company&#146;s common stock on the grant date. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;7.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Regulation FD Disclosure. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;30, 2018, the Company issued a press release announcing the
election of Mr.&nbsp;Lerman to the Board. A copy of the Company&#146;s press release is attached hereto as Exhibit 99.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained in
this item, including Exhibit 99.1, is furnished to the Commission, but shall not be deemed &#147;filed&#148; with the Commission for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or
incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Exhibits. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:25.30pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d542849dex991.htm">Press release issued by the Company dated April&nbsp;30, 2018. </A></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: April&nbsp;30, 2018 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>McKesson Corporation</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Lori&nbsp;A.&nbsp;Schechter</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lori A. Schechter</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Vice President, General Counsel and</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Compliance Officer</TD></TR>
</TABLE></DIV>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d542849dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g542849sp6.gif" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contact </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">McKesson Corporation
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Craig Mercer, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">415-983-8391</FONT></FONT> (Investors and Financial Media) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Craig.Mercer@McKesson.com </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kristin Hunter Chasen, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">415-983-8974</FONT></FONT> (General and Business Media) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Kristin.Chasen@McKesson.com </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>McKesson
Board of Directors Elects Brad Lerman as </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>New Independent Director </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SAN FRANCISCO, April&nbsp;30, 2018 &#150; McKesson Corporation (NYSE: MCK) today announced that its Board of Directors has elected Brad Lerman
as a new independent director, effective April&nbsp;24, 2018. With the election of Mr.&nbsp;Lerman, the size of McKesson&#146;s Board of Directors increases from eight to nine members, eight of whom are independent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;With more than 25 years of experience bringing insights that bridge compliance and government relations with corporate strategy, Brad
will be an immediate asset to McKesson&#146;s Board of Directors,&#148; said John H. Hammergren, chairman and chief executive officer, McKesson. &#147;His deep understanding of the healthcare industry and experience in the public and private sectors
bring valuable insights to our Board. We have an ongoing commitment to regularly refreshing and strengthening our Board, and Brad is a perfect match for the background we were seeking in this search process.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;McKesson is a renowned industry leader and the Company possesses a strong foundation for long-term growth. I look forward to working
collaboratively with my board colleagues to help guide the Company in advancing its mission to deliver better health to all,&#148; added Brad Lerman. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">McKesson regularly engages with its shareholders on corporate governance matters such as board composition and refreshment. &#147;Our director
selection process continues to equip the Board with the right mix of qualifications, perspectives, and experiences. The addition of Brad enhances our Board&#146;s overall skill set and supports the execution of McKesson&#146;s strategy, which is
designed to deliver long-term growth and sustainable value creation for shareholders,&#148; said Edward Mueller, McKesson&#146;s lead independent director. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Brad Lerman </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Lerman, age 61, is
senior vice president, general counsel and corporate secretary for Medtronic. He leads the company&#146;s global legal, government affairs and ethics and compliance functions. Prior to Medtronic, Brad served as executive vice president, general
counsel and corporate secretary for the Federal National Mortgage Association (Fannie Mae) and as senior vice president, associate general counsel and chief litigation counsel for Pfizer. For a decade, Mr.&nbsp;Lerman served as a private practice
attorney and litigation partner at Winston&nbsp;&amp; Strawn LLP in Chicago. Prior to private practice, he served as a federal prosecutor for the U.S. Department of Justice, where he was an assistant U.S. attorney in the Northern District of
Illinois for eight years. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g542849sp6.gif" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About McKesson Corporation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">McKesson Corporation, currently ranked 5<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>&nbsp;on the FORTUNE 500, is a global leader in
healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other
organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to
innovate and deliver opportunities that make our customers and partners more successful&#150;all for the better health of patients. McKesson has been named the &#147;<U>Most Admired Company</U>&#148; in the healthcare wholesaler category by FORTUNE,
a &#147;<U>Best Place to Work</U>&#148; by the Human Rights Campaign Foundation, and a top&nbsp;<U>military-friendly company</U>&nbsp;by Military Friendly. For more information, visit&nbsp;<U>www.mckesson.com</U>. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g542849sp6.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542849sp6.gif
M1TE&.#EA5P,] /4  /____?Z^[_6XJ?&UY_!U-_J\=?E[8>QR;?0WJ_+VX^V
MS,_@Z4"$J0!:C"!OFTB)K2ATGN_U^'BHPN?O]'^LQ1!DDV"8N%".L#!YHCA^
MI<?;Y@A?D!AJEUB3M'"COY>\T&B=N__\^?WET?[NXO[RZ/>61OJ^C
M
M                                 "P     5P,]   (_P !"!Q(L*#!
M@P@3*ES(L*'#AQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+
MES!CRIQ)LZ;-FSASZMS)LZ?/GT"#"AU*M*A( 0D(""BPLH  !0B6+D2J0("
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M(NH (,GAK$4#=!/,!BA0D 00SBT8J)_<-A"8"J1NAODR"(*L1\A6NO*5(%F
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59W5*Q'WF]WUB=8 (F( *F%$! 0 [

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
